Companies / Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc.
Nasdaq: AARDCIK 1774857SAN DIEGO, CA
Financials
Ownership
21.9M shares outstanding · as of Jul 31, 2026
Ownership
| Institutions | 47.38% | 10,369,999 |
| Public float | 52.62% | 11,514,847 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 3
View all →| Insider | % of shares | Shares |
|---|---|---|
Jaiman ManasiChief Medical Officer | — | — |
Lee Tien-LiCEOChief Executive Officer · Director · 10% owner | — | — |
Sun NelsonChief Financial Officer | — | — |
Institutional holders 74
View all →| Holder | Value | % of shares |
|---|---|---|
| $51.41M | 17.90% | |
| $16.92M | 5.89% | |
| $9.42M | 3.28% | |
| $6.26M | 2.18% | |
| $3.99M | 1.39% | |
| $3.90M | 4.73% | |
| $1.88M | 0.65% | |
| $1.28M | 0.45% | |
| $1.17M | 0.41% | |
| $1.17M | 1.41% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common Stock | $-3.44M | -597K -76.16% | 187,045 0.85% of shares | low |
| Q3 2025 as of | Cresset Asset Management, LLC 13F manager | New | Common Stock | $1.88M | +142K | 141,783 0.65% of shares | low |
| Q4 2025 as of | Cresset Asset Management, LLC 13F manager | Exit | Common Stock | $-1.88M | -142K -100.00% | — | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common Stock | $-1.45M | -385K -79.66% | 98,334 0.45% of shares | low |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | Common Stock | $1.13M | +300K | 300,000 1.37% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | New | Common Stock | $683.5K | +51K | 50,558 0.23% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common Stock | $-570.0K | -99K -62.54% | 59,273 0.27% of shares | low |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | New | Common Stock | $507.0K | +134K | 134,495 0.61% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AARD | Common Stock | 002942100 |